Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine

The bile acid sequestering agent Vasosan P is a new form of pectin-enriched cholestyramine (20%), saccharose (5%) and sorbic acid (0.18%). In comparison with cholestyramine Vasosan P has a more marked hypolipidemic effect in experiment. Vasosan P is remarkable for good organoleptic properties. It is...

Full description

Saved in:

Bibliographic Details
Published in:	Kardiologiia Vol. 30; no. 8; p. 77
Main Authors:	Ryzhenkov, V E, Chistiakova, A M, Triufanov, V F, Vasil'eva, L E, Frolova, Iu V, Solov'eva, M A, Remezova, O V, Lozovskiĭ, V T, Khanefel'd, M, Leonkhardt, V
Format:	Journal Article
Language:	Russian
Published:	Russia (Federation) 01-08-1990
Subjects:	Animals Cholesterol - blood Cholestyramine Resin - adverse effects Cholestyramine Resin - therapeutic use Guinea Pigs Humans Hypercholesterolemia - blood Hypercholesterolemia - drug therapy Hyperlipoproteinemia Type II - blood Hyperlipoproteinemia Type II - drug therapy Lipid Metabolism Lipids - blood Lipoproteins, VLDL - blood Liver - metabolism Rats Triglycerides - blood
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The bile acid sequestering agent Vasosan P is a new form of pectin-enriched cholestyramine (20%), saccharose (5%) and sorbic acid (0.18%). In comparison with cholestyramine Vasosan P has a more marked hypolipidemic effect in experiment. Vasosan P is remarkable for good organoleptic properties. It is effective in treating patients with type IIa hyperlipoproteinemia and practically has no side effects as cholestyramine.
ISSN:	0022-9040